Skip to main content

Find Clinical Trials

Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,437 public trials 2,853 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Not yet recruiting

Study of NK Cells in the Monitoring of Patients With Acute Leukemia or Myelodysplasia

NCT07249476

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: CHU de Nantes Nantes, France

View Trial Details

Not yet recruiting

Study of Alternative and Approved Dosing Regimens of Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Participants With Relapsed/Refractory Multiple Myeloma

NCT07614360

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Not yet recruiting

Atorvastatin Combined With NAC Plus Romiplostim for Management of ITP

NCT07662525

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Peking University People's Hospital Beijing, China

View Trial Details

Not yet recruiting

A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic Transplant

NCT07572929

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +14 more
Locations: Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Not yet recruiting

Cousin vs. Sibling Donors in Haplo-HSCT

NCT07662382

Conditions: Donor, Haploidentical Hematopoietic Stem Cell Transplantation, Hematologic Diseases, +5 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Not yet recruiting

ELDORADO: Elranatamab Versus Daratumumab in Combination With RVd Lite for Newly Diagnosed Transplant Ineligible/Deferred Multiple Myeloma

NCT07247097

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Not yet recruiting

Menin-Inhibitor Targeted Maintenance in AML

NCT07563010

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

GPRC5D Targeted PET/CT Imaging in Plasma Cell Disorders

NCT07660939

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

View Trial Details

Not yet recruiting

Immunological Impact of a Post Cell Therapy Treatment With FLT3 Inhibitors

NCT06992934

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
Locations: CHU de NICE Nice, France

View Trial Details

Not yet recruiting

Connected Blood Pressure Monitoring in Patients With Hematologic Malignancies Initiating Covalent BTK Inhibitors

NCT07592481

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +34 more
Locations: Not specified

View Trial Details